Synthesis of 9-Deoxo-4‘‘-deoxy-6,9-epoxyerythromycin Derivatives: Novel and Acid-Stable Motilides

Abstract
In our quest toward the discovery of highly potent and acid-stable motilides, novel 4‘‘-deoxy derivatives of 9-deoxo-6,9-epoxyerythromycin were designed, synthesized, and evaluated for their gastrointestinal prokinetic activities. These compounds, in their 9R configuration, were more potent than their 6,9-enol ether homologues in inducing well-coordinated smooth muscle contractions in an in vitro rabbit duodenal assay: e.g., (9R),(8S)-9-deoxo-4‘‘-deoxy-3‘-N-desmethyl-3‘-N-ethyl-6,9-epoxyerythromycin A (10) and (9R),(8S)-9-deoxo-4‘‘-deoxy-3‘-N-desmethyl-3‘-N-ethanol-6,9-epoxyerythromycin A (15) had a pED50 of 8.54 and 8.11 compared to a pED50 of 7.22 for compound 2 (ABT-229). Reduction of the 6,9-enol ether, which was aimed at improving the acid stability, afforded the most stable motilides to date with t1/2 of 5.5 h for 10 and 15. Compounds 10 and 15 bind specifically to rabbit antral smooth muscle motilin receptors with pIC50 values of 8.52 and 8.70.

This publication has 11 references indexed in Scilit: